Kenneth Aguirre, MD
Interventional Pain Medicine · Saint Clairsville, OHNPI 1639529589
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,262 of the $1,846 with a category attached, or 68.4%. 17 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 28.5% of the total. Reporting peaked in 2024 at $861 and has fallen 65.4% since, to $298 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.
Across 36 payments — averaging $51.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$525
- Medtronic$490
- SPR Therapeutics, Inc$416
- Abbott$97
- AstraZeneca$52
- Collegium Pharmaceutical, Inc.$39
- plus $226 from 11 others
What the payments were for
- Travel & lodging$47025%
- Food & beverage$1,26268%
- Education$1146%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 6 | $525 |
| Medtronic | 8 | $490 |
| SPR Therapeutics, Inc | 4 | $416 |
| Abbott | 1 | $97 |
| AstraZeneca | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $30 |
| Bioventus LLC | 1 | $27 |
| Vertex | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Midsouth Orthopedics Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| AbbVie | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$431
- SPRINT PNS System$314
- INTELLIS ADAPTIVESTIM$283
How this compares
$1,846 in reported general payments places this provider in the 25th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $10,592 |
| Celecoxib | 12 | $910 |
| Gabapentin | 77 | $842 |
| Duloxetine Hcl | 36 | $725 |
| Pregabalin | 48 | $610 |
| Atorvastatin Calcium | 53 | $393 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $353 |
| Pantoprazole Sodium | 14 | $313 |
| Nifedipine ErNifedipine | 18 | $263 |
| Naproxen | 35 | $255 |
| Glipizide ErGlipizide | 14 | $243 |
| Losartan Potassium | 23 | $231 |
| Lisinopril | 29 | $231 |
| Omeprazole | 16 | $213 |
| Methocarbamol | 22 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $15 | $10,59211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 67 interventional pain medicine providers in Ohio.
Other interventional pain medicine in Saint Clairsville
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.